MoneyWorks4Me

Hikal informs about analyst meet intimation

30 Jan 2023 Evaluate
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), Hikal has informed that, the Company will hold the earnings conference call to discuss the financial and operational performance for the quarter and nine months ended December 31, 2022, on Thursday, February 2, 2023 at 04:30 PM IST. The details of the conference call including the dial-in details are attached herewith. This information is submitted pursuant to Regulation 30(6) of the SEBI Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..